News & Knowledge
Meet some of Sanome’s brilliant Clinical Advisory team. Comprised of nurses, NHS Doctors and beyond.
To mark National Engineering Day, we sat down with Sanome’s Engineering Lead, Eddie Pease, to find out more about his engineering journey.
Sanome has been selected to join the 2022/23 cohort of the Digital Health London Evidence Generation Programme.
Sanome has received funding to support the development and evidence generation of its biomarker-based early warning system for patients receiving long-term specialist inpatient care.
PatientSource and Sanome are excited to announce their new partnership to revolutionise early warning systems for health deteriorations in hospital and care settings.
Sanome Principal Sponsor and keynote speaker at Cambridge University BioScience Enterprise 20 Years on celebration.
Sanome’s James Withers, shares his insights and the impact of IBM Watson sale with ERP Today.
Sanome has been recognized as a top tech and life-sciences company in the Ones2Watch 2021 award by Business Weekly.
The competition involves companies from pioneering start-ups to game changing leaders in their field and therefore is a fantastic achievement for Sanome to be named in this list.
Sanome is delighted to join the South East Health Technologies Alliance (SEHTA).
To mark International Women’s Day 2023, we invite you to meet some of the incredible women who have supported Sanome in the journey so far.
The RHN is a leading provider of specialist healthcare and neuro-rehabilitation services, serving patients with severe and complex neuro-disability, and Sanome is committed to developing cutting-edge technology solutions to improve patient outcomes.
Founder & CEO Benedikt von Thüngen spoke at AWS event, showcasing Sanome’s technology and sharing insights into the power and potential of generative AI for healthcare.
“AstraZeneca isn’t the only pharmaceutical business pursuing digital-twin research. […] U.K.-based startup Sanome is working toward a digital twin to detect health changes as early as possible.”
Sanome awarded i4i FAST Grant to develop Early Warning Systems for health deteriorations.
“The shortlist for #21toWatch 2023 has been announced by Cofinitive - and once again showcases the next-generation of game-changers and innovators.”
Sanome's Founder and CEO Benedikt von Thüngen on CNBC morning news discussing the volatility of the markets following the collapse of SVB and the impact that this could have for healthcare and life sciences innovation in particular.
Sanome is delighted that Co-Founder, Paul Aykroyd has accepted the role of COO.
Meet some of Sanome’s brilliant Technical Advisory team. Comprised of experts in the field of machine learning, data science, bioinformatics and AI.
Dr Andrew Creagh joins the Sanome team as Lead AI/ML Scientist, from his post at Oxford University.
Sanome were invited to The House of Lords to share healthcare and healthtech insights & innovation with the NHS Directorate.
Catch up on Sanome’s Founder & CEO, Benedikt von Thüngen’s interview with PKV-Verband.
Sanome has been named Most Innovative Biomarker Platform 2023 by the Global Health & Pharma Awards, within the International Life Sciences Awards category.
Sanome was invited to join the ‘Future of Healthcare Investment Forum’ at the London Stock Exchange.
Find out what Sanome has been up to over the summer, our key learnings and takeaways from the legislators, clinicians and industry experts.
Sanome recognised on SpeedInvest list - Digital Health in Europe: How the UK is Leading the Digital Transformation of Healthcare
Sanome’s machine learning and data science team attended the five-day conference, hosted by the Cambridge Centre for AI in Medicine. Tom Pease, Data Scientist, reviews.
Sanome attended The Healthcare Excellence Through Technology 2023 Conference.
Sanome identifies biomarkers from routine blood tests that can aid in the early detection of colorectal cancer (bowel, colon). This finding could lead to better and/or earlier detection of cancer.
Sanome’s Founder & CEO, Benedikt von Thüngen, spoke at the Heal Capital investor day in Berlin.
Sanome raises £2m to drive forward clinically validated home testing using combination biomarkers
A strong case study highlighting the importance of awareness of health literacy.
This paper was co-authored by Dr Andrew Creagh, PhD (Oxon.), Sanome’s Lead AI/ML Scientist.
This paper was co-authored by Hon Professor Haitham Bou Ammar, Sanome’s Lead Reinforcement Learning Advisor.
Sanome publishes article on Open Access Government, turns the spotlight onto diagnostic hubs.
Founder & CEO Benedikt von Thüngen, wrote a feature for Technology Networks about the new era of Digital Twin Diagnostics.